119 related articles for article (PubMed ID: 27824162)
1. Fibroblast miR-210 overexpression is independently associated with clinical failure in Prostate Cancer - a multicenter (in situ hybridization) study.
Andersen S; Richardsen E; Moi L; Donnem T; Nordby Y; Ness N; Holman ME; Bremnes RM; Busund LT
Sci Rep; 2016 Nov; 6():36573. PubMed ID: 27824162
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA 141 is associated to outcome and aggressive tumor characteristics in prostate cancer.
Richardsen E; Andersen S; Melbø-Jørgensen C; Rakaee M; Ness N; Al-Saad S; Nordby Y; Pedersen MI; Dønnem T; Bremnes RM; Busund LT
Sci Rep; 2019 Jan; 9(1):386. PubMed ID: 30674952
[TBL] [Abstract][Full Text] [Related]
3. Stromal expression of MiR-21 predicts biochemical failure in prostate cancer patients with Gleason score 6.
Melbø-Jørgensen C; Ness N; Andersen S; Valkov A; Dønnem T; Al-Saad S; Kiselev Y; Berg T; Nordby Y; Bremnes RM; Busund LT; Richardsen E
PLoS One; 2014; 9(11):e113039. PubMed ID: 25401698
[TBL] [Abstract][Full Text] [Related]
4. High miR-205 expression in normal epithelium is associated with biochemical failure - an argument for epithelial crosstalk in prostate cancer?
Nordby Y; Richardsen E; Ness N; Donnem T; Patel HRH; Busund LT; Bremnes RM; Andersen S
Sci Rep; 2017 Nov; 7(1):16308. PubMed ID: 29176717
[TBL] [Abstract][Full Text] [Related]
5. The potential of microRNAs as human prostate cancer biomarkers: A meta-analysis of related studies.
Song CJ; Chen H; Chen LZ; Ru GM; Guo JJ; Ding QN
J Cell Biochem; 2018 Mar; 119(3):2763-2786. PubMed ID: 29095529
[TBL] [Abstract][Full Text] [Related]
6. miR-150 is a factor of survival in prostate cancer patients.
Dezhong L; Xiaoyi Z; Xianlian L; Hongyan Z; Guohua Z; Bo S; Shenglei Z; Lian Z
J BUON; 2015; 20(1):173-9. PubMed ID: 25778313
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy.
Li T; Gui Y; Yuan T; Liao G; Bian C; Jiang Q; Huang S; Liu B; Wu D
BJU Int; 2012 Dec; 110(11 Pt C):E1125-30. PubMed ID: 22672360
[TBL] [Abstract][Full Text] [Related]
8. Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer.
Andersen S; Richardsen E; Rakaee M; Bertilsson H; Bremnes R; Børset M; Busund LT; Slørdahl T
PLoS One; 2017; 12(11):e0189000. PubMed ID: 29190795
[TBL] [Abstract][Full Text] [Related]
9. Significantly altered expression of miR-511-3p and its target AKT3 has negative prognostic value in human prostate cancer.
Zhang F; Wu Z
Biochimie; 2017 Sep; 140():66-72. PubMed ID: 28624527
[TBL] [Abstract][Full Text] [Related]
10. Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling.
Kristensen H; Thomsen AR; Haldrup C; Dyrskjøt L; Høyer S; Borre M; Mouritzen P; Ørntoft TF; Sørensen KD
Oncotarget; 2016 May; 7(21):30760-71. PubMed ID: 27120795
[TBL] [Abstract][Full Text] [Related]
11. Gene expressional changes in prostate fibroblasts from cancerous tissue.
Reinertsen T; Halgunset J; Viset T; Flatberg A; Haugsmoen LL; Skogseth H
APMIS; 2012 Jul; 120(7):558-71. PubMed ID: 22716211
[TBL] [Abstract][Full Text] [Related]
12. Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer.
Musumeci M; Coppola V; Addario A; Patrizii M; Maugeri-Saccà M; Memeo L; Colarossi C; Francescangeli F; Biffoni M; Collura D; Giacobbe A; D'Urso L; Falchi M; Venneri MA; Muto G; De Maria R; Bonci D
Oncogene; 2011 Oct; 30(41):4231-42. PubMed ID: 21532615
[TBL] [Abstract][Full Text] [Related]
13. Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer.
Tsuchiyama K; Ito H; Taga M; Naganuma S; Oshinoya Y; Nagano K; Yokoyama O; Itoh H
Prostate; 2013 Jun; 73(8):827-34. PubMed ID: 23184537
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
[TBL] [Abstract][Full Text] [Related]
15. Low Expression of miR-424-3p is Highly Correlated with Clinical Failure in Prostate Cancer.
Richardsen E; Andersen S; Al-Saad S; Rakaee M; Nordby Y; Pedersen MI; Ness N; Ingebriktsen LM; Fassina A; Taskén KA; Mills IG; Donnem T; Bremnes RM; Busund LT
Sci Rep; 2019 Jul; 9(1):10662. PubMed ID: 31337863
[TBL] [Abstract][Full Text] [Related]
16. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
Cai C; Chen QB; Han ZD; Zhang YQ; He HC; Chen JH; Chen YR; Yang SB; Wu YD; Zeng YR; Qin GQ; Liang YX; Dai QS; Jiang FN; Wu SL; Zeng GH; Zhong WD; Wu CL
Clin Cancer Res; 2015 Nov; 21(21):4922-34. PubMed ID: 26080838
[TBL] [Abstract][Full Text] [Related]
17. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.
Sun X; Yang Z; Zhang Y; He J; Wang F; Su P; Han J; Song Z; Fei Y
Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409
[TBL] [Abstract][Full Text] [Related]
18. Profiling of microRNAs in exosomes released from PC-3 prostate cancer cells.
Hessvik NP; Phuyal S; Brech A; Sandvig K; Llorente A
Biochim Biophys Acta; 2012; 1819(11-12):1154-63. PubMed ID: 22982408
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer.
Lee CT; Capodieci P; Osman I; Fazzari M; Ferrara J; Scher HI; Cordon-Cardo C
Clin Cancer Res; 1999 May; 5(5):977-83. PubMed ID: 10353729
[TBL] [Abstract][Full Text] [Related]
20. Low miR-143/miR-145 Cluster Levels Induce Activin A Overexpression in Oral Squamous Cell Carcinomas, Which Contributes to Poor Prognosis.
Bufalino A; Cervigne NK; de Oliveira CE; Fonseca FP; Rodrigues PC; Macedo CC; Sobral LM; Miguel MC; Lopes MA; Paes Leme AF; Lambert DW; Salo TA; Kowalski LP; Graner E; Coletta RD
PLoS One; 2015; 10(8):e0136599. PubMed ID: 26317418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
